Ronit Simantov

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New Haven, CT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nicholas Maestas, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ronit Simantov

Form 4 holding CMO & CHIEF SCIENTIFIC OFFICER

Gamida Cell Ltd.

Security class
Ordinary Shares
Shares / value
655,896
Estimated value
$1,016,639
Report date
31 Jan 2024
Price
$1.55
Ownership
Direct
Form 4 holding CMO & CHIEF SCIENTIFIC OFFICER

Gamida Cell Ltd.

Security class
Employee Share Option (Right to Buy)
Shares / value
116,340
Estimated value
Report date
08 Feb 2023
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

Clovis Oncology, Inc.

Security class
Stock Option (right to buy)
Shares / value
83,212
Estimated value
Report date
12 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Ronit Simantov

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .